Skip to main content

Table 7 EORTC prostate cancer module (QLQ-PR25) at timepoint of evaluation [Mean 3.2 (SD: 2.8) years after end of radiotherapy]

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

PR25 functional scores Value (mean/± SD/median)
Sexual activity (PRSAC-score) 36.8/29.4/33.3
Sexual functioning (PRSFU-score) 47.2/25.4/33.3
PR25 Symptom scores Value (mean/± SD/median)
Urinary symptoms (PRURI-score) 24.9/20.8/19.5
Bowel symptoms (PRBOWE-score) 6.6/9.2/0.0
Hormonal treatment-related symptoms (PRHTR-score) 18.0/14.9/16.7
Incontinence aid (PRAID-score) 24.6/32.2/0.0